Completeness of reporting and risks of overstating impact in cluster randomised trials: a systematic review
| Autor: | Elizabeth L Turner, Alyssa C Platt, John A Gallis, Kaitlin Tetreault, Christina Easter, Joanne E McKenzie, Stephen Nash, Andrew B Forbes, Karla Hemming, Christine Adrion, Naseerah Akooji, Hannah Bensoussane, Aneel Bhangu, Jon Bishop, Bernadeta Bridgwood, Eric Budgell, Agnès Caille, Michael Campbell, Shiwei Cao, Claire Louise Chan, Versha Cheed, Michelle Collinson, Andrew Copas, Stephanie N Dixon, Sandra Eldridge, Alice S Forster, Alicia Gill, Bruno Giraudeau, Alan Girling, James Glasbey, Beatriz Goulao, Kelsey L Grantham, Simon Hackett, Thomas Hamborg, Kelly Handley, Monica Harding, Pollyanna Hardy, Catherine A Hewitt, Richard Hooper, Natalie Ives, Kirsty James, Christopher I Jarvis, Ben Jones, Brennan C Kahan, Mona Kanaan, Jessica Kasza, Lindsay Kendall, Caroline Kristunas, Kristie Kusibab, Hui-Jie Lee, Clémence Leyrat, Stephanie J Macneill, Vichithranie W Madurasinghe, James Martin, Ariane M Mbekwe Yepnang, Kara McCormack, Samir Mehta, Mirjam Moerbeek, Kelly Moran, Lazaro Mwakesi Mwandigha, Lee Aymar Ndouga Diakou, Dmitri Nepogodiev, Omar Omar, Laura A Pankhurst, Alice Parish, Smitaa Patel, Hayley Perry, Ines Rombach, Ryan Simmons, Beth Stuart, Yongzhong Sun, Monica Taljaard, Elsa Tavernier, Jennifer A Thompson, Tracy Truong, Joao Ricardo Vissoci, Adam P Wagner, Tongrong Wang, Xueqi Wang, Jeremy Weber, Nina Wilson, Jonathan Wilson, Rebecca Woolley, Siyun Yang, Zidanyue Yang |
|---|---|
| Přispěvatelé: | Group, CRT Binary Outcome Reporting |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Randomized Controlled Trials as Topic/standards
Risk medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Psychological intervention Multicomponent interventions MEDLINE General Medicine Disease cluster Article Primary outcome Research Design Global health Cluster Analysis Humans Medicine business Intensive care medicine Research Design/standards Randomized Controlled Trials as Topic |
| Zdroj: | The Lancet Global Health, 9(8), e1163. Elsevier BV Lancet Glob Health |
| ISSN: | 2214-109X |
| Popis: | Overstating the impact of interventions through incomplete or inaccurate reporting can lead to inappropriate scale-up of interventions with low impact. Accurate reporting of the impact of interventions is of great importance in global health research to protect scarce resources. In global health, the cluster randomised trial design is commonly used to evaluate complex, multicomponent interventions, and outcomes are often binary. Complete reporting of impact for binary outcomes means reporting both relative and absolute measures. We did a systematic review to assess reporting practices and potential to overstate impact in contemporary cluster randomised trials with binary primary outcome. We included all reports registered in the Cochrane Central Register of Controlled Trials of two-arm parallel cluster randomised trials with at least one binary primary outcome that were published in 2017. Of 73 cluster randomised trials, most (60 [82%]) showed incomplete reporting. Of 64 cluster randomised trials for which it was possible to evaluate, most (40 [63%]) reported results in such a way that impact could be overstated. Care is needed to report complete evidence of impact for the many interventions evaluated using the cluster randomised trial design worldwide. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|